These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 25232237)
1. MicroRNAs as potential biomarkers for gastric cancer. Liu HS; Xiao HS World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237 [TBL] [Abstract][Full Text] [Related]
2. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. Shin VY; Chu KM World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759 [TBL] [Abstract][Full Text] [Related]
3. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as promising biomarkers for gastric cancer. Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. Ahadi A IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236 [TBL] [Abstract][Full Text] [Related]
6. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Wu HH; Lin WC; Tsai KW Expert Rev Mol Med; 2014 Jan; 16():e1. PubMed ID: 24456939 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. Matuszcak C; Haier J; Hummel R; Lindner K World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504 [TBL] [Abstract][Full Text] [Related]
8. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment. Mirzajani E; Vahidi S; Norollahi SE; Samadani AA Microrna; 2022; 11(1):12-24. PubMed ID: 35319404 [TBL] [Abstract][Full Text] [Related]
9. Altered MiRNA expression in gastric cancer: a systematic review and meta-analysis. Wang QX; Zhu YQ; Zhang H; Xiao J Cell Physiol Biochem; 2015; 35(3):933-44. PubMed ID: 25633747 [TBL] [Abstract][Full Text] [Related]
10. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
11. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer. Liu X; Chu KM J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer. Mu YP; Sun WJ; Lu CW; Su XL Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of non-coding RNAs in gastric cancer. Yang Q; Zhang RW; Sui PC; He HT; Ding L World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. Huang YK; Yu JC World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393 [TBL] [Abstract][Full Text] [Related]
15. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer. Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960 [TBL] [Abstract][Full Text] [Related]
16. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. da Silva Oliveira KC; Thomaz Araújo TM; Albuquerque CI; Barata GA; Gigek CO; Leal MF; Wisnieski F; Rodrigues Mello Junior FA; Khayat AS; de Assumpção PP; Rodriguez Burbano RM; Smith MC; Calcagno DQ World J Gastroenterol; 2016 Sep; 22(35):7951-62. PubMed ID: 27672290 [TBL] [Abstract][Full Text] [Related]
17. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications. Xie SS; Jin J; Xu X; Zhuo W; Zhou TH World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325 [TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Su Y; Ni Z; Wang G; Cui J; Wei C; Wang J; Yang Q; Xu Y; Li F Int Immunopharmacol; 2012 Aug; 13(4):468-75. PubMed ID: 22683180 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. Mirzaei H; Khataminfar S; Mohammadparast S; Sales SS; Maftouh M; Mohammadi M; Simonian M; Parizadeh SM; Hassanian SM; Avan A Curr Med Chem; 2016; 23(36):4135-4150. PubMed ID: 27538692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]